APA (7th ed.) Citation

K, N., K, I., S, N., N, H., & H, W. (2025). Pembrolizumab-Induced Aplastic Anemia Successfully Treated With Thrombopoietin Receptor Agonist in a Patient With Lung Adenocarcinoma: A Case Report and Literature Review. Cureus, 17(12), e98931. https://doi.org/10.7759/cureus.98931

Chicago Style (17th ed.) Citation

K, Namba, Isobe K, Nakao S, Hiruta N, and Wakabayashi H. "Pembrolizumab-Induced Aplastic Anemia Successfully Treated With Thrombopoietin Receptor Agonist in a Patient With Lung Adenocarcinoma: A Case Report and Literature Review." Cureus 17, no. 12 (2025): e98931. https://doi.org/10.7759/cureus.98931.

MLA (9th ed.) Citation

K, Namba, et al. "Pembrolizumab-Induced Aplastic Anemia Successfully Treated With Thrombopoietin Receptor Agonist in a Patient With Lung Adenocarcinoma: A Case Report and Literature Review." Cureus, vol. 17, no. 12, 2025, p. e98931, https://doi.org/10.7759/cureus.98931.